Bortezomib and High-dose Melphalan at Myeloma Relapse

NCT00508209 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: bortezomib

Sponsor

Nordic Myeloma Study Group

Collaborators

[object Object]